Mice with constitutively active SREBP1 in adipose tissue exhibited lipodystrophy and metabolic dysfunction, driven by reduced adipogenic gene programs, further implicating SREBP1 with impaired WAT function (53). The gene discussed is SREBF1; the disease is lipodystrophy.